Pacira Pharmaceuticals Inc (PCRX)

41.08
1.59 4.03
NASDAQ : Health Care
Prev Close 39.49
Open 39.65
Day Low/High 39.45 / 41.60
52 Wk Low/High 31.08 / 80.25
Volume 839.98K
Avg Volume 808.10K
Exchange NASDAQ
Shares Outstanding 37.28M
Market Cap 1.50B
EPS 0.10
P/E Ratio 55.08
Div & Yield N.A. (N.A)

Latest News

Trade-Ideas: Pacira Pharmaceuticals (PCRX) Is Today's

Trade-Ideas: Pacira Pharmaceuticals (PCRX) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Pacira Pharmaceuticals (PCRX) Flagged As Strong On High Volume

Pacira Pharmaceuticals (PCRX) Flagged As Strong On High Volume

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a strong on high relative volume candidate

September 16th Options Now Available For Pacira Pharmaceuticals (PCRX)

September 16th Options Now Available For Pacira Pharmaceuticals (PCRX)

Investors in Pacira Pharmaceuticals Inc. saw new options become available today, for the September 16th expiration.

Pacira Pharmaceuticals (PCRX) Is Today's Dead Cat Bounce Stock

Pacira Pharmaceuticals (PCRX) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Today's Dead Cat Bounce Stock Is Pacira Pharmaceuticals (PCRX)

Today's Dead Cat Bounce Stock Is Pacira Pharmaceuticals (PCRX)

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Pacira Pharmaceuticals (PCRX) Is Weak On High Volume Today

Pacira Pharmaceuticals (PCRX) Is Weak On High Volume Today

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a weak on high relative volume candidate

Pacira Pharmaceuticals (PCRX) Showing Signs Of Perilous Reversal Today

Pacira Pharmaceuticals (PCRX) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "perilous reversal" (up big yesterday but down big today) candidate

Bearish Bets: 5 Stocks That Look Like Good Buys on the Short Side

UFS, PCRX, AAL, BEN and BHE were all recently downgraded by TheStreet’s Quant Ratings.

Today's Dead Cat Bounce Stock Is Pacira Pharmaceuticals (PCRX)

Today's Dead Cat Bounce Stock Is Pacira Pharmaceuticals (PCRX)

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABCD, ABX, AEG, AMBC, AZN, BK, CBG, CBT, CNA, CSTE, DO, EEP, GBX, GRC, HHC, NWFL, OFIX, RJF, ROG, RVSB, SBAC, SCCO, SLM, TOT Downgrades: ATRC, BSFT, CZNC, PCRX, VICR, WTM Initiations: RYAM Read on to get TheStreet Quant Ratings' detailed report:

Today's Dead Cat Bounce Stock: Pacira Pharmaceuticals (PCRX)

Today's Dead Cat Bounce Stock: Pacira Pharmaceuticals (PCRX)

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate

PCRX: Insiders vs. Shorts

PCRX: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 03/31/2016 settlement date, and Pacira Pharmaceuticals Inc. is one of the most shorted stocks of the Russell 3000, based on 10.18 "days to cover" versus the median component at 5.89.

Pacira Pharmaceuticals (PCRX) Marked As A Dead Cat Bounce Stock

Pacira Pharmaceuticals (PCRX) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate

New Analysis Shows Use Of EXPAREL Reduces Length Of Hospital Stay And Improves Discharge Status Compared To Standard Analgesic Modality In Total Knee Arthroplasty

New Analysis Shows Use Of EXPAREL Reduces Length Of Hospital Stay And Improves Discharge Status Compared To Standard Analgesic Modality In Total Knee Arthroplasty

Data Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons

Pacira Pharmaceuticals (PCRX) Stock Price Target Cut at Jefferies

Pacira Pharmaceuticals (PCRX) Stock Price Target Cut at Jefferies

Jefferies lowered its price target on Pacira Pharmaceuticals (PCRX) stock and maintained its ‘buy’ rating.

Pacira Pharmaceuticals (PCRX) Stock Slumps Following Q4 Results

Pacira Pharmaceuticals (PCRX) Stock Slumps Following Q4 Results

Pacira Pharmaceuticals (PCRX) stock is falling on Thursday after the company reported its 2015 fourth quarter results before today’s opening bell.